Literature DB >> 26293823

Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients.

Stanley C Jordan1.   

Abstract

Entities:  

Keywords:  HLA; allograft; antibody

Mesh：

Substances：

Year:  2015        PMID： 26293823      PMCID： PMC4696592          DOI： 10.1681/ASN.2015060608

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

1.  Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.

Authors:  J Sellarés; D G de Freitas; M Mengel; J Reeve; G Einecke; B Sis; L G Hidalgo; K Famulski; A Matas; P F Halloran
Journal:  Am J Transplant       Date:  2011-11-14       Impact factor: 8.086

2.  Rituximab for IgG4-related disease: a prospective, open-label trial.

Authors:  Mollie N Carruthers; Mark D Topazian; Arezou Khosroshahi; Thomas E Witzig; Zachary S Wallace; Philip A Hart; Vikram Deshpande; Thomas C Smyrk; Suresh Chari; John H Stone
Journal:  Ann Rheum Dis       Date:  2015-02-09       Impact factor: 19.103

3.  Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information.

Authors:  A R Tambur; N D Herrera; K M K Haarberg; M F Cusick; R A Gordon; J R Leventhal; J J Friedewald; D Glotz
Journal:  Am J Transplant       Date:  2015-04-30       Impact factor: 8.086

Review 4.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

5.  Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.

Authors:  M D Stegall; T Diwan; S Raghavaiah; L D Cornell; J Burns; P G Dean; F G Cosio; M J Gandhi; W Kremers; J M Gloor
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

6.  Diagnostic challenges in chronic antibody-mediated rejection.

Authors:  Evan A Farkash; Robert B Colvin
Journal:  Nat Rev Nephrol       Date:  2012-03-27       Impact factor: 28.314

7.  Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year.

Authors:  L D Cornell; C A Schinstock; M J Gandhi; W K Kremers; M D Stegall
Journal:  Am J Transplant       Date:  2015-03-02       Impact factor: 8.086

8.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

Authors:  F K Port; R A Wolfe; E A Mauger; D P Berling; K Jiang
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

Review 9.  The spectrum of antibody-mediated renal allograft injury: implications for treatment.

Authors:  J Gloor; F Cosio; D J Lager; M D Stegall
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

10.  Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Dewi Vernerey; Jean-Paul Duong-Van-Huyen; Caroline Suberbielle; Dany Anglicheau; Jérôme Vérine; Thibaut Beuscart; Dominique Nochy; Patrick Bruneval; Dominique Charron; Michel Delahousse; Jean-Philippe Empana; Gary S Hill; Denis Glotz; Christophe Legendre; Xavier Jouven
Journal:  Lancet       Date:  2012-11-23       Impact factor: 79.321
View more
  4 in total

Review 1.  Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.

Authors:  Angus W Thomson; Abhinav Humar; Fadi G Lakkis; Diana M Metes
Journal:  Hum Immunol       Date:  2017-10-31       Impact factor: 2.850

2.  Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.

Authors:  Louisa Kühne; Bettina Jung; Helen Poth; Antonia Schuster; Simone Wurm; Petra Ruemmele; Bernhard Banas; Tobias Bergler
Journal:  BMC Immunol       Date:  2017-12-19       Impact factor: 3.615

3.  Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization.

Authors:  Shenzhen Tempest-Roe; Maria Prendecki; Stephen P McAdoo; Candice Clarke; Anisha Tanna; Tabitha Turner-Stokes; Esteban S Masuda; Michelle Willicombe; H Terence Cook; Candice Roufosse; David Taube; Charles D Pusey; Frederick W K Tam
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

4.  A new flow cytometry assay identifies recipient IgG subtype antibodies binding donor cells: increasing donor availability for highly sensitised patients.

Authors:  Prakash N Rao; Dayanand D Deo; Amitabh Gaur; David A Baran; Mark J Zucker; Saurabh Kapoor; Misty A Marchioni; Jesus Almendral; Praveen Kandula; Anup Patel
Journal:  Clin Transl Immunology       Date:  2022-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.